載入...
Lipoprotein(a) Lowering—From Lipoprotein Apheresis to Antisense Oligonucleotide Approach
It is well-known that elevated lipoprotein(a)—Lp(a)—levels are associated with a higher risk of cardiovascular (CV) mortality and all-cause mortality, although a standard pharmacotherapeutic approach is still undefined for patients with high CV risk dependent on hyperlipoproteinemia(a). Combined wit...
Na minha lista:
| 發表在: | J Clin Med |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7408876/ https://ncbi.nlm.nih.gov/pubmed/32635396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9072103 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|